IV Options

Recommendation

De-escalate to narrowest spectrum IV antibiotic based on susceptibility results (ampicillin, ampicillin-sulbactam, cefazolin, ceftriaxone, etc.)

May switch to PO if tolerating PO and clinically well appearing